LSD Set To Remain Class A Drug
New Zealand - LSD is set to remain a Class A drug following discussion by the country's Expert Advisory Committee on Drugs.
Minutes from a March meeting of the Committee - released to Radio New Zealand under the Official Information Act - show it will not make any recommendation on the number of Class A drugs.
Nor will there be any recommendation on LSD "at this time".
A report to the committee comparing LSD and Methamphetamine, which was made a Class A drug three years ago, showed the latter has more severe health effects and links to serious criminal offending.
It says no research has been done on whether a lower classification for LSD would lead to greater use or whether such a move would be "tolerated by society".